These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 2859145

  • 1. Medullary thyroid carcinoma and calcitonin.
    Emmertsen K.
    Dan Med Bull; 1985 Mar; 32(1):1-28. PubMed ID: 2859145
    [Abstract] [Full Text] [Related]

  • 2. Surgical treatment of medullary carcinoma of the thyroid.
    Block MA.
    Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Provocative testing for occult medullary carcinoma of the thyroid: findings in seven children with multiple endocrine neoplasia type IIa.
    Graham SM, Genel M, Touloukian RJ, Barwick KW, Gertner JM, Torony C.
    J Pediatr Surg; 1987 Jun; 22(6):501-3. PubMed ID: 2886576
    [Abstract] [Full Text] [Related]

  • 6. Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2.
    Telander RL, Zimmerman D, van Heerden JA, Sizemore GW.
    J Pediatr Surg; 1986 Dec; 21(12):1190-4. PubMed ID: 2878988
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of procalcitonin measurement in patients after total thyroidectomy due to medullary thyroid carcinoma.
    Bolko P, Manuszewska-Jopek E, Michałek K, Waśko R, Jaskuła M, Sowiński J.
    Arch Immunol Ther Exp (Warsz); 2003 Dec; 51(6):415-9. PubMed ID: 14692663
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Experience with a provocative test of calcitonin release as a prospective screening for preclinical medullary thyroid carcinoma in MEN type 2A family members.
    van Lathem JJ, Vermaak WJ, Kuyl JM, Mollentze W, Jansen S, Wolmarans L, Pelser H, Barry R, Kruger AJ, Wolfaardt M.
    J Clin Lab Anal; 1992 Dec; 6(6):384-90. PubMed ID: 1359042
    [Abstract] [Full Text] [Related]

  • 14. Medullary carcinoma of the thyroid: differentiating the types and current management.
    Samaan NA, Hickey RC.
    Oncology (Williston Park); 1987 Dec; 1(10):21-8. PubMed ID: 2908613
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of region specific radioimmunoassays for characterization of circulating calcitonin in patients with medullary carcinoma of the thyroid gland.
    Myhre L, Gautvik KM.
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):449-61. PubMed ID: 474037
    [Abstract] [Full Text] [Related]

  • 17. Medullary carcinoma of the thyroid. (Clinical and endocrinological features of six cases).
    degli Uberti EC, Trasforini G, Bagni B, Liboni A, Pansini GC, Altavilla G.
    Ric Clin Lab; 1981 Jul; 11(2):171-8. PubMed ID: 7268276
    [Abstract] [Full Text] [Related]

  • 18. Radioimmunoassay of calcitonin in plasma, normal thyroid, and medullary thyroid carcinoma of the rat.
    Roos BA, Deftos LJ, Roberts G, Wilson P, Bundy L.
    J Lab Clin Med; 1976 Aug; 88(2):173-82. PubMed ID: 822106
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.